Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Porter

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Urologic Oncology|July 4, 2016
Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998-2011)Cory M Hugen, Brian Hu, Claudio Jeldres, et al.
Urology|May 11, 2005
Model to predict prostate biopsy outcome in large screening population with independent validation in referral settingChristopher R Porter, Eduard J Gamito, E David Crawford, et al.
The Canadian Journal of Urology|October 27, 2010
Does a perioperative belladonna and opium suppository improve postoperative pain following robotic assisted laparoscopic radical prostatectomy? Results of a single institution randomized studyStephen Lukasewycz, Matt Holman, Paul Kozlowski, et al.
Urology|November 14, 2002
Predicting the outcome of prostate biopsy in a racially diverse population: a prospective studyChristopher R Porter, Colin O'Donnell, E David Crawford, et al.
The Journal of Urology|August 10, 2015
Prostate Needle Biopsy Outcomes in the Era of the U.S. Preventive Services Task Force Recommendation against Prostate Specific Antigen Based ScreeningJohn S Banerji, Erika M Wolff, John D Massman, et al.
The Journal of Urology|July 4, 2006
25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution seriesChristopher R Porter, Koichi Kodama, Robert P Gibbons, et al.
The Journal of Urology|May 13, 2015
Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance--How Many Cores are Enough?Khanh N Pham, Christopher R Porter, Katherine Odem-Davis, et al.
Urology|March 17, 2018
Evolution of the Ureteral Stent: The Pivotal Role of the Gibbons Ureteral CatheterRyan P Donahue, Andrew W Stamm, Robert P Gibbons, et al.
BJU International|November 22, 2008
Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control studyChristopher R Porter, Umberto Capitanio, Paul Perrotte, et al.
The Journal of Urology|November 21, 2002
Role of advanced 2 and 3-dimensional ultrasound for detecting prostate cancerK C Balaji, William R Fair, Ernst J Feleppa, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Urologic Oncology|July 4, 2016
Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998-2011)Cory M Hugen, Brian Hu, Claudio Jeldres, et al.
Urology|May 11, 2005
Model to predict prostate biopsy outcome in large screening population with independent validation in referral settingChristopher R Porter, Eduard J Gamito, E David Crawford, et al.
The Canadian Journal of Urology|October 27, 2010
Does a perioperative belladonna and opium suppository improve postoperative pain following robotic assisted laparoscopic radical prostatectomy? Results of a single institution randomized studyStephen Lukasewycz, Matt Holman, Paul Kozlowski, et al.
Urology|November 14, 2002
Predicting the outcome of prostate biopsy in a racially diverse population: a prospective studyChristopher R Porter, Colin O'Donnell, E David Crawford, et al.
The Journal of Urology|August 10, 2015
Prostate Needle Biopsy Outcomes in the Era of the U.S. Preventive Services Task Force Recommendation against Prostate Specific Antigen Based ScreeningJohn S Banerji, Erika M Wolff, John D Massman, et al.
The Journal of Urology|July 4, 2006
25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution seriesChristopher R Porter, Koichi Kodama, Robert P Gibbons, et al.
The Journal of Urology|May 13, 2015
Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance--How Many Cores are Enough?Khanh N Pham, Christopher R Porter, Katherine Odem-Davis, et al.
Urology|March 17, 2018
Evolution of the Ureteral Stent: The Pivotal Role of the Gibbons Ureteral CatheterRyan P Donahue, Andrew W Stamm, Robert P Gibbons, et al.
BJU International|November 22, 2008
Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control studyChristopher R Porter, Umberto Capitanio, Paul Perrotte, et al.
The Journal of Urology|November 21, 2002
Role of advanced 2 and 3-dimensional ultrasound for detecting prostate cancerK C Balaji, William R Fair, Ernst J Feleppa, et al.
Pageof 6